Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-23-054739

President & Co-CEO acquired 21,269,420 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Chirag K. President & Co-CEO 2023-11-07 Other acquisition +21,269,420 21,269,420 I
Derivatives
Patel Chirag K. President & Co-CEO 2023-11-07 Other disposition · Class B Common Stock and Common Units −21,269,420 0 I
Loading xslF345X05/doc4.xml…